| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |